SCPH scPharmaceuticals
- 3.510
- +0.110+3.24%
- 3.340
- -0.170-4.84%
scPharmaceuticals所有资讯
scPharmaceuticals | 4：持股变动声明-高管 Nokes Rachael
scPharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-J. Luther King, Jr.(5.8%),Luther King Capital Management Corporation(5.5%)
scPharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Lundbeckfond Invest A/S (“Lundbeckfond”)(5.7%),Lene Skole (“Skole”)(5.7%)
scPharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Laurence W. Lytton(5.9%)
scPharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-J. Luther King, Jr.(4.6%),Luther King Capital Management Corporation(4.5%)
scPharmaceuticals | 4：持股变动声明-董事 SCHAEFFER LEONARD D
scPharmaceuticals | 4/A：持股变动声明(修正)-高管 Nokes Rachael
scPharmaceuticals | 4：持股变动声明-股东 ORBIMED ADVISORS LLC
scPharmaceuticals | SC 13D/A：超过5%持股股东披露文件(修正)-OrbiMed Advisors LLC(12.1%),OrbiMed Capital GP VI LLC(11.6%)等
scPharmaceuticals | 4：持股变动声明-高管 Nokes Rachael
scPharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-J. Luther King, Jr.(6.4%),Luther King Capital Management Corporation(6.1%)
scPharmaceuticals | 4：持股变动声明-董事 Khattar Jack A.
scPharmaceuticals | 4：持股变动声明-董事 Hudson Frederick M.
scPharmaceuticals | 4：持股变动声明-董事 Agger Mette Kirstine
scPharmaceuticals | 4：持股变动声明-董事 SCHAEFFER LEONARD D
scPharmaceuticals | 4：持股变动声明-董事 Abraham William Tober
scPharmaceuticals | 4：持股变动声明-董事 VEITINGER KLAUS R DR
scPharmaceuticals | 4：持股变动声明-董事 Baylor-Henry Minnie
scPharmaceuticals | 4：持股变动声明-董事 Bonstein Sara
scPharmaceuticals | SC 13G：超过5%持股股东披露文件-J. Luther King, Jr.(5.3%),Luther King Capital Management Corporation(5.0%)
暂无数据